We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LN
3551
DELISTED
LINE Corporation
LN
$1K ﹤0.01%
45
-272
-86% -$8.56K
PRCP
3552
DELISTED
Perceptron Inc
PRCP
$1K ﹤0.01%
+130
New +$769
GMHIU
3553
DELISTED
Gores Metropoulos, Inc. Unit
GMHIU
$1K ﹤0.01%
138
+40
+41% +$413
FORK
3554
DELISTED
Fuling Global Inc
FORK
$1K ﹤0.01%
+302
New +$679
WMGI
3555
DELISTED
Wright Medical Group Inc
WMGI
$1K ﹤0.01%
22
-1,348
-98% -$41.1K
BITA
3556
DELISTED
Bitauto Holdings Limited
BITA
$1K ﹤0.01%
63
-4,094
-98% -$49.5K
FTACU
3557
DELISTED
FinTech Acquisition Corp. III Unit
FTACU
$1K ﹤0.01%
69
GRAF.U
3558
DELISTED
Graf Industrial Corp. Units, each consisting of One share of Common Stock and One redeemable Warrant
GRAF.U
$1K ﹤0.01%
71
-66
-48% -$679
ASFI
3559
DELISTED
Asta Funding Inc
ASFI
$1K ﹤0.01%
100
-412
-80% -$2.43K
JE
3560
DELISTED
Just Energy Group Inc
JE
$1K ﹤0.01%
4
-96
-96% -$11.6K
CYRXW
3561
DELISTED
CryoPort, Inc. Warrants
CYRXW
$1K ﹤0.01%
97
GPAQU
3562
DELISTED
Gordon Pointe Acquisition Corp. Unit
GPAQU
$1K ﹤0.01%
100
POPE
3563
DELISTED
Pope Resources Depositary Receipts of Limited Partnership Units
POPE
$1K ﹤0.01%
+8
New +$541
FTSV
3564
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$1K ﹤0.01%
68
-2,435
-97% -$35.7K
WRLSU
3565
DELISTED
Pensare Acquisition Corp. Unit
WRLSU
$1K ﹤0.01%
+100
New +$1.06K
BCRH
3566
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$1K ﹤0.01%
77
-4,684
-98% -$33K
DPLO
3567
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1K ﹤0.01%
187
-1,802
-91% -$9.58K
AVP
3568
DELISTED
Avon Products, Inc.
AVP
$1K ﹤0.01%
181
-24,742
-99% -$82.4K
QTRH
3569
DELISTED
Quarterhill Inc. Common Shares
QTRH
$1K ﹤0.01%
1,000
-4,639
-82% -$5.03K
HSACU
3570
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
$1K ﹤0.01%
+76
New +$792
TBLTU
3571
DELISTED
ToughBuilt Industries, Inc. Class A Units
TBLTU
$1K ﹤0.01%
+314
New +$1.17K
DFBHU
3572
DELISTED
DFB Healthcare Acquisitions Corp. Unit
DFBHU
$1K ﹤0.01%
+64
New +$663
ROX
3573
DELISTED
Castle Brands, Inc.
ROX
$1K ﹤0.01%
2,917
-13,446
-82% -$7.85K
BRACU
3574
DELISTED
Black Ridge Acquisition Corp. Unit
BRACU
$1K ﹤0.01%
+101
New +$1.1K
ASCMA
3575
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$1K ﹤0.01%
+791
New +$718

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.